PUNE, India, March 22, 2018 /PRNewswire/ --
According to a new market research report "Humanized
Mouse and Rat Model Market by Type (Genetic, Cell-Based
(CD34, PBMC, BLT)), Application (Neuroscience, Hematopoesis,
Oncology, Immunology & Infectious Diseases) & End User
(Pharmaceutical & Biotechnology Companies, CRO)) - Global
Forecast to 2022", published by MarketsandMarkets™, the
Humanized Mouse Model Market is projected to reach USD 128.9 Million by 2022 from USD 80.3 Million in 2017, at a CAGR of 9.9%
during the forecast period. The humanized rat models market is
expected to reach USD 8.9 Million by
2022 from USD 5.9 Million in 2017, at
a CAGR of 8.4% during the forecast period. Growth in this market
can primarily be attributed to factors such as the growing demand
of personalized medicine, continuous support in the form of
investments and grants from the government and private sectors,
increasing number of R&D activities in pharmaceutical and
biotechnology companies, and the increasing number of research
activities involving humanized models. Increasing production of
monoclonal antibodies and rising demand for humanized rat models
are expected to provide a wide range of growth opportunities for
players in the market.
(Logo:
http://photos.prnewswire.com/prnh/20160303/792302 )
Browse 94 market data Tables and 42 Figures spread through
189 Pages and in-depth TOC on "Humanized
Mouse and Rat Model Market"
https://www.marketsandmarkets.com/Market-Reports/humanized-mouse-model-market-131763955.html
Early buyers will receive 10% customization
on this report
The oncology segment commanded the largest share of the
Humanized Mouse Model Market in 2017
By application, the Humanized Mouse Model Market is categorized
into oncology, immunology and infectious diseases, neuroscience,
hematopoiesis, toxicology, and other applications. Of all these
application segments, oncology accounted for the largest share of
the Humanized Mouse Model Market in 2017. The increasing research
activities and growing funding from various governments to carry
out research studies on cancer are the major factors driving the
growth of this segment.
Cell-based humanized mouse models to grow at the highest CAGR
during the forecast period
By type, the Humanized Mouse Model Market is categorized into
genetic and cell-based humanized mouse models. The cell-based
humanized mouse models segment is expected to grow at the highest
CAGR during the study period (2017-2022). The high growth of this
segment can be attributed to the growing applications of cell-based
humanized mouse models.
The cell-based humanized mouse models segment is further
categorized into CD34, PBMC, and BLT humanized mouse models. In
2017, the CD34 models segment commanded the largest share of the
cell-based Humanized Mouse Model Market and is expected to grow at
the highest CAGR during the forecast period. CD34 mouse models are
used as in vivo platforms for analyzing the safety and
effectiveness of potential new drugs that can modulate the immune
system. They are used for long-term studies in the fields of
immuno-oncology, infectious disease, and graft versus host disease.
Thus, the growing application areas of CD34 models are expected to
trigger the demand for these models in the coming years.
Ask for PDF Brochure @
https://www.marketsandmarkets.com/pdfdownload.asp?id=131763955
Contract Research Organizations (CROs) to dominate the
Humanized Mouse Model Market during the forecast
period
By end user, the Humanized Mouse Model Market is categorized
into pharmaceutical & biotechnology companies, contract
research organizations (CRO), and academic & research
institutions. The contract research organizations (CROs) segment is
projected to grow at the highest CAGR during the forecast period.
Growth in this segment is largely due to the increasing number of
pharmaceutical companies outsourcing their preclinical studies to
contract research organizations (CROs).
North America dominated the
market in 2017
North America dominated the
global Humanized Mouse Model Market in 2017. Growth in this
regional segment can be attributed to the increasing monoclonal
antibody production, preclinical activities by CROs and
pharmaceutical R&D, continued and responsible use of animals
ensured by animal care organizations, growing biomedical research
in the US along with government support for the development of
protein drugs, and growing stem cell research in Canada.
The major market players in the Humanized Mouse Model Market
include The Jackson Laboratory (US), Taconic Biosciences, Inc.
(US), Horizon Discovery Group plc (UK), genOway, S.A. (France), Charles River Laboratories (US),
Harbour Antibodies BV (China),
Hera BioLabs (US), Vitalstar Biotechnology Co., Ltd. (China), inGenious Targeting Laboratory (US),
AXENIS S.A.S (France), Crown
Bioscience, Inc. (US), Transgenic, Inc. (Japan), and Champions Oncology, Inc. (US). The
major players in the humanized rat models market include Horizon
Discovery Group plc (UK), Hera BioLabs (US), and Yecuris
Corporation (US).
Know more about the Humanized Mouse and Rat Model
Market:
https://www.marketsandmarkets.com/Market-Reports/humanized-mouse-model-market-131763955.html
About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000
high growth niche opportunities/threats which will impact 70% to
80% of worldwide companies' revenues. Currently servicing 5000
customers worldwide including 80% of global Fortune 1000 companies
as clients. Almost 75,000 top officers across eight industries
worldwide approach MarketsandMarkets™ for their painpoints around
revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are
tracking global high growth markets following the "Growth
Engagement Model - GEM". The GEM aims at proactive collaboration
with the clients to identify new opportunities, identify most
important customers, write "Attack, avoid and defend" strategies,
identify sources of incremental revenues for both the company and
its competitors. MarketsandMarkets™ now coming up with 1,500
MicroQuadrants (Positioning top players across leaders, emerging
companies, innovators, strategic players) annually in high growth
emerging segments. MarketsandMarkets™ is determined to benefit more
than 10,000 companies this year for their revenue planning and help
them take their innovations/disruptions early to the market by
providing them research ahead of the curve.
MarketsandMarkets's flagship competitive intelligence and market
research platform, "RT" connects over 200,000 markets and entire
value chains for deeper understanding of the unmet insights along
with market sizing and forecasts of niche markets.
Contact:
Mr. Salgarkar
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Connect with us on LinkedIn @
http://www.linkedin.com/company/marketsandmarkets